Orion Pharma Limited reported unaudited consolidated earnings results for third quarter and nine months ended March 31, 2018. For the quarter, the company’s EPS was BDT 0.69 for against BDT 0.56 for same period a year ago. For the nine months, the company’s EPS was BDT 2.76 against BDT 3.02 for same period a year ago. NOCFPS was BDT 8.57 against BDT 8.54 for same period a year ago.